Skip to content
Movie Casting Call
Author:
CDT Equity Inc.
CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
September 29, 2026
CDT Equity Inc. Announces Reverse Stock Split
September 25, 2026
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
September 18, 2026
CDT Highlights Sarborg’s Application of Signature Intelligence and Quantum Computing Models to Mental Health
September 10, 2026
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
September 2, 2026
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
September 1, 2026
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
August 28, 2026
CDT Announces Investment in Pep’d, Expanding into the Fast-Growing US Peptide Market
August 25, 2026
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
August 3, 2026
CDT Highlights Sarborg’s Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane
July 20, 2026
1
2
Next Page
→